Top Markets
Coin of the day
Health Sciences Group, Inc. Health Sciences Group, Inc.

Health Sciences Group, Inc.

HESG
Rang in Aktien #37259
Operating through its various subsidiaries, Health Sciences Group Inc. (HESG)... Operating through its various subsidiaries, Health Sciences Group Inc. (HESG) specializes in supplying a range of ingredients and finished products for the nutritional supplement and functional food and beverage sectors across the United States. Key among its offerings is Shugr, an innovative, calorie-free sugar alternative meticulously formulated to replicate the taste and baking properties of traditional cane sugar. Another notable product is the Sequesterol Advance Cardio Formula, a proprietary blend featuring clinically validated ingredients designed to support robust cardiovascular well-being and maintain optimal blood circulation. The company's portfolio further includes Aplevia, an antioxidant extracted from apple peels, and Edible Sponges, an open-cell hydrocolloid product. Distribution channels for these products are diverse, encompassing major retail chains — such as mass merchandisers, pharmacies, grocery stores, and discount outlets — alongside sales to healthcare professionals, practitioners, and various other media platforms. Tracing its origins to 1996 as Centurion Properties Development Corporation, the company underwent a name change to iGoHealthy.com in 2000, before adopting its current designation, Health Sciences Group, Inc., in 2001. Its corporate headquarters are situated in Newport Beach, California.
Aktienkurs
$0.0001
Zuletzt synchronisiert: 2026-08-13
Marktkapitalisierung
$1.87M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
9,900.00%
Land
US
Handel Health Sciences Group, Inc. (HESG)

Kategorie

P/B-Verhältnis für Health Sciences Group, Inc. (HESG)
P/B-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Health Sciences Group, Inc. beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/B-Verhältnis bei 0.
P/B-Verlauf für Health Sciences Group, Inc. von 2026 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/B-Verhältnis P/B-Verhältnis-Differenz Land
6.3419 -
US
6.2413 -
NL
- -
CH
- -
KR
3.4612 -
BE